SCHEMBL21498144

SCHEMBL21498144

COc1ccc(CCC(=O)N(CCCCN)CCCNCCCN(CCCCN)C(=O)CCc2ccc(OC)c(OC)c2)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
APP P05067 1/20 0.47
KDM4E B2RXH2 2/20 0.47
ATM Q13315 1/20 0.47
ACHE P22303 1/20 0.47
POLB P06746 1/20 0.46
HDAC3 O15379 3/20 0.46
HDAC1 Q13547 3/20 0.46
HDAC2 Q92769 3/20 0.46
HDAC8 Q9BY41 3/20 0.46
HDAC4 P56524 2/20 0.46
HDAC7 Q8WUI4 2/20 0.46
HDAC10 Q969S8 2/20 0.46
HDAC11 Q96DB2 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
HDAC9 Q9UKV0 2/20 0.46
HDAC5 Q9UQL6 2/20 0.46
PLAAT3 P53816 1/20 0.46
PLAAT5 Q96KN8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25695874 0.97 CDK8 (0.49) CDK8CLK4APPKDM4EATM
SCHEMBL21498140 0.92 CDK8 (0.49) CDK8CLK4APPKDM4EATM
SCHEMBL21498148 0.87 CDK8 (0.42) CDK8CLK4APPKDM4EATM
SCHEMBL11654613 0.79 KDM4E (0.65) KDM4EATMPOLBKMT2ACA12
SCHEMBL21498146 0.78 MAPT (0.45) APPKDM4EHDAC3HDAC1HDAC2
SCHEMBL7175921 0.77 PLAAT3 (0.54) KDM4EATMPOLBHDAC3HDAC1
SCHEMBL28549332 0.77 SLC2A1 (0.67) KDM4EATMPOLBKMT2ACA12
SCHEMBL11934971 0.77 SLC2A1 (0.67) KDM4EATMPOLBKMT2ACA12
SCHEMBL10518881 0.76 KDM4E (0.65) KDM4EATMPOLBKMT2ACA12
SCHEMBL21498147 0.75 ELANE (0.52) KDM4EPOLBHDAC3HDAC2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10449167-B2 Polyamine derivative medicinal salt and preparation method and use Chongqing Antixin Biotechnology Co., LTD. (CN) 2019-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10449167-B2 Polyamine derivative medicinal salt and preparation method and use SRM, TLR9, SELP CDK8 3852/4885CLK4 1422/4885APP 3986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.